Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ)
CNY 6.79
(1.19%)
CNY 6.79
(1.19%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 330.85 Million CNY | 17.68% |
| 2022 | 251.48 Million CNY | 39.32% |
| 2021 | 180.5 Million CNY | -32.95% |
| 2020 | 269.22 Million CNY | 84.56% |
| 2019 | 145.87 Million CNY | -50.29% |
| 2018 | 293.47 Million CNY | 71.72% |
| 2017 | 170.89 Million CNY | -11.77% |
| 2016 | 193.68 Million CNY | 108.29% |
| 2015 | 92.98 Million CNY | 133.39% |
| 2014 | 39.84 Million CNY | 1.52% |
| 2013 | 39.24 Million CNY | -10.58% |
| 2012 | 43.89 Million CNY | 14.04% |
| 2011 | 38.48 Million CNY | -21.33% |
| 2010 | 48.92 Million CNY | 23.78% |
| 2009 | 39.52 Million CNY | 25.08% |
| 2008 | 31.6 Million CNY | -4.43% |
| 2007 | 33.06 Million CNY | 83.88% |
| 2006 | 17.98 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 43.95 Million CNY | -36.19% |
| 2024 Q1 | 78.53 Million CNY | 24.58% |
| 2024 Q2 | 68.88 Million CNY | -12.29% |
| 2023 Q3 | 54.61 Million CNY | -36.96% |
| 2023 Q1 | 115.79 Million CNY | 357.31% |
| 2023 Q4 | 63.04 Million CNY | 15.42% |
| 2023 FY | 295.93 Million CNY | 17.68% |
| 2023 Q2 | 86.63 Million CNY | -25.18% |
| 2022 Q3 | 47.75 Million CNY | -46.54% |
| 2022 FY | 251.48 Million CNY | 39.32% |
| 2022 Q4 | 25.32 Million CNY | -46.97% |
| 2022 Q2 | 89.31 Million CNY | 0.24% |
| 2022 Q1 | 89.09 Million CNY | 162.23% |
| 2021 Q3 | 15.98 Million CNY | -71.66% |
| 2021 Q1 | 74.13 Million CNY | 424.15% |
| 2021 Q2 | 56.4 Million CNY | -23.91% |
| 2021 Q4 | 33.97 Million CNY | 112.56% |
| 2021 FY | 180.5 Million CNY | -32.95% |
| 2020 Q3 | -43.3 Million CNY | -170.25% |
| 2020 Q2 | 61.64 Million CNY | -9.09% |
| 2020 Q1 | 67.81 Million CNY | 119.99% |
| 2020 FY | 269.22 Million CNY | 84.56% |
| 2020 Q4 | -22.87 Million CNY | 47.19% |
| 2019 Q1 | 93.53 Million CNY | 14.4% |
| 2019 FY | 145.87 Million CNY | -50.29% |
| 2019 Q3 | -331.34 Million CNY | -520.13% |
| 2019 Q4 | -339.21 Million CNY | -2.37% |
| 2019 Q2 | 78.86 Million CNY | -15.68% |
| 2018 Q1 | 73.18 Million CNY | 663.28% |
| 2018 FY | 293.47 Million CNY | 71.72% |
| 2018 Q3 | 57.15 Million CNY | -29.77% |
| 2018 Q4 | 81.75 Million CNY | 43.05% |
| 2018 Q2 | 81.37 Million CNY | 11.2% |
| 2017 Q2 | 80.75 Million CNY | 103.87% |
| 2017 Q1 | 39.6 Million CNY | -32.98% |
| 2017 Q3 | 40.94 Million CNY | -49.29% |
| 2017 FY | 170.89 Million CNY | -11.77% |
| 2017 Q4 | 9.58 Million CNY | -76.58% |
| 2016 Q1 | 47.48 Million CNY | 55.96% |
| 2016 Q2 | 50.56 Million CNY | 6.49% |
| 2016 FY | 193.68 Million CNY | 108.29% |
| 2016 Q3 | 36.53 Million CNY | -27.74% |
| 2016 Q4 | 59.1 Million CNY | 61.76% |
| 2015 FY | 92.98 Million CNY | 133.39% |
| 2015 Q4 | 30.44 Million CNY | 37.62% |
| 2015 Q2 | 25.14 Million CNY | 64.63% |
| 2015 Q1 | 15.27 Million CNY | 100.51% |
| 2015 Q3 | 22.12 Million CNY | -12.02% |
| 2014 Q2 | 13.87 Million CNY | 0.46% |
| 2014 Q3 | 4.54 Million CNY | -67.22% |
| 2014 Q4 | 7.61 Million CNY | 67.54% |
| 2014 FY | 39.84 Million CNY | 1.52% |
| 2014 Q1 | 13.8 Million CNY | 316.1% |
| 2013 Q4 | 3.31 Million CNY | 91.8% |
| 2013 Q2 | 12.02 Million CNY | -45.77% |
| 2013 Q3 | 1.73 Million CNY | -85.61% |
| 2013 FY | 39.24 Million CNY | -10.58% |
| 2013 Q1 | 22.17 Million CNY | 649.8% |
| 2012 Q3 | 9.48 Million CNY | -41.57% |
| 2012 FY | 43.89 Million CNY | 14.04% |
| 2012 Q4 | 2.95 Million CNY | -68.82% |
| 2012 Q1 | 15.2 Million CNY | 175.94% |
| 2012 Q2 | 16.23 Million CNY | 6.76% |
| 2011 Q3 | 6.97 Million CNY | -47.49% |
| 2011 Q1 | 12.71 Million CNY | 51.2% |
| 2011 Q2 | 13.29 Million CNY | 4.55% |
| 2011 Q4 | 5.5 Million CNY | -21.05% |
| 2011 FY | 38.48 Million CNY | -21.33% |
| 2010 Q2 | 13.04 Million CNY | 28.12% |
| 2010 Q4 | 8.4 Million CNY | -51.37% |
| 2010 Q3 | 17.28 Million CNY | 32.46% |
| 2010 Q1 | 10.18 Million CNY | 60.55% |
| 2010 FY | 48.92 Million CNY | 23.78% |
| 2009 Q1 | -11.23 Million CNY | -537.31% |
| 2009 Q4 | 6.34 Million CNY | -58.69% |
| 2009 Q3 | 15.35 Million CNY | -47.16% |
| 2009 Q2 | 29.05 Million CNY | 358.72% |
| 2009 FY | 39.52 Million CNY | 25.08% |
| 2008 FY | 31.6 Million CNY | -4.43% |
| 2008 Q3 | 10.13 Million CNY | 0.0% |
| 2008 Q4 | 2.56 Million CNY | -74.65% |
| 2007 FY | 33.06 Million CNY | 83.88% |
| 2006 FY | 17.98 Million CNY | 0.0% |